Thiopurine therapy in inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

Thiopurine therapy in inflammatory bowel disease.

Thiopurine therapy in inflammatory bowel disease.

http://www.wikidata.org/entity/Q37798819

about

Use of thiopurines in inflammatory bowel disease: Safety issues.A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease.Early Thiopurines Versus Conventional Step-Care Therapy for Modifying the Disease Course of Early Crohn's Disease: A Tertiary Referral Center Cohort Study.Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.Clinical implications of ageing for the management of IBD.Toxicity and response to thiopurines in patients with inflammatory bowel disease.Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients.Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.Outcome predictors for thiopurine maintenance therapy in patients with Crohn's disease.Mucosal Healing in Ulcerative Colitis: A Comprehensive Review.

P2860

Q33621267-D1FA2CC9-5D49-4481-B28B-1BB2A74B2990 Q36078334-4495B22C-305A-4F44-AB0B-83681D1CC006 Q36194780-B0C8CA49-DFF6-49FD-85BB-889605F4B02D Q37570037-C4351421-C595-4625-A95C-83C193C7AB8C Q38171926-FABCE8D1-A5DA-4097-B6E8-D0595728357F Q38443981-C2282040-967A-489F-9AB8-1D691F37A3E1 Q40382305-253A53D9-7741-42DB-910D-1F4532C99B15 Q40478934-05DD77ED-D15B-4E57-A114-C2349A3E2A2A Q43749263-E177C98A-853A-4A39-BBED-DD8E4878AF47 Q51392532-4F0C041F-EAC2-416A-9F46-AF8A82E80E75 Q53815697-35C20388-A130-4404-803B-19D30BD5829C

P2860

Thiopurine therapy in inflammatory bowel disease.

http://www.wikidata.org/entity/Q37798819

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Thiopurine therapy in inflammatory bowel disease.

@en

Thiopurine therapy in inflammatory bowel disease.

@nl

type

label

Thiopurine therapy in inflammatory bowel disease.

@en

Thiopurine therapy in inflammatory bowel disease.

@nl

prefLabel

Thiopurine therapy in inflammatory bowel disease.

@en

Thiopurine therapy in inflammatory bowel disease.

@nl

P1433

Q37798819-BEC26B64-819C-4F51-8EA6-587BEACE51CA

P1476

Q37798819-9CBDF2DC-900D-4D4A-9F6D-4AE469EC4A9E

P2093

Q37798819-9B1E2C6D-4184-4F4F-A045-057C65768F19

Q37798819-A14A61B3-BB98-4FAF-9231-B67AEAFC6402

P2860

Q37798819-00D1957E-ED5C-496B-8417-D93170A65B93

Q37798819-053ACA07-6CE2-4B11-8F4A-8F297E4B572A

Q37798819-08676AB0-9004-463B-9316-78498A904319

Q37798819-0A9C70FE-DDE3-4113-B92E-23BD4D5A1FAE

Q37798819-14C6B589-96AA-41F4-B317-45938B109B7A

Q37798819-16CB7B9A-662F-48F2-8F61-DC161B6139C1

Q37798819-17BD35DB-C820-4DB8-A9C4-62720F5D5E09

Q37798819-1BECDB9B-D2CE-4442-8F0D-D100696B0EF9

Q37798819-23FFC911-ED8A-42AE-B493-B5F4888C7276

Q37798819-26B04DC7-D9D5-40F8-AD24-F52E21643512

P304

Q37798819-123DB9F1-8747-4900-815E-8861019742E7

P31

Q37798819-2ABD421F-5472-417E-A08F-07DA69856A88

P356

Q37798819-996F70EE-DD56-40EA-9FE0-7FEA747B8F28

P433

Q37798819-EA6B2C10-0CDA-4AB4-ADC2-014E29FA4683

P478

Q37798819-BF3DBACC-5427-4E2D-BA72-5911DC66B573

P577

Q37798819-0D31396D-967B-428B-826A-15F9D21697BF

P698

Q37798819-15B5889D-28FC-4A35-8F68-5A1427ABEEAB

P921

Q37798819-0D6EC6E5-B650-4401-9517-1165453CDF60

Q37798819-B58E8AA3-4B31-4A93-A995-9EA305544EE3

P356

P1433

Expert Review of Gastroenterology & Hepatology

P1476

Thiopurine therapy in inflammatory bowel disease.

@en

P2093

Christina Ha

http://www.w3.org/2001/XMLSchema#string

Themistocles Dassopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

A controlled trial of azathioprine in Crohn's disease

Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.

P304

575-588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/EGH.10.59

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20932143

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases